Rho-Kinase/ROCK as a Potential Drug Target for Vitreoretinal Diseases

Rho-associated kinase (Rho-kinase/ROCK) was originally identified as an effector protein of the G protein Rho. Its involvement in various diseases, particularly cancer and cardiovascular disease, has been elucidated, and ROCK inhibitors have already been applied clinically for cerebral vasospasm and...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamaguchi, Muneo, Nakao, Shintaro, Arima, Mitsuru, Wada, Iori, Kaizu, Yoshihiro, Hao, Feng, Yoshida, Shigeo, Sonoda, Koh-hei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5449758/
https://www.ncbi.nlm.nih.gov/pubmed/28596919
http://dx.doi.org/10.1155/2017/8543592

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5449758/
https://www.ncbi.nlm.nih.gov/pubmed/28596919
http://dx.doi.org/10.1155/2017/8543592

Ejemplares similares